I'm very excited to share that I will be joining
@Amgen, overseeing cardiometabolic research and human genetics, starting Aug 3!
I am excited to shape target identification, biology, and drug discovery as the therapeutic area head for cardiovascular disease, obesity, and general medicine. And I will lead the human genetics efforts, spanning Amgen deCODE genetics (a subsidiary of Amgen), that drive target discovery and biology across all therapeutic areas.
I have been incredibly fortunate to interface with truly remarkable individuals and culture across
@MassGenBrigham,
@broadinstitute, and
@harvardmed, where I could not have asked for a more meaningful and enjoyable academic career.
Being able to build on my prior work, discover and clarify therapeutic hypotheses, and now carry them through to medicines that reach millions is an opportunity I'm grateful for. I'm very excited for what comes next.